Skip to main content
. 2019 Oct 31;14(6):647–657. doi: 10.1111/irv.12688

Table 1.

Sentinel site profile, WHO RSV surveillance, 2017‐18

  Age‐group under surveillance Patients under surveillance # sentinel sites Start of surveillance

No. tested

(% hospitalized)

Argentina All ages Inpatient 6 2016 wk52 1214 (99%)
Australia 0‐18 y Inpatient 1 2017 wk31 1560 (100%)
Brazil All ages Inpatient 2 2017 wk03 727 (91%)
Canada 0‐16 y Inpatient 12 2017 wk34 2178a (100%)
Chile All ages Inpatient 2 2017 wk01 883 (100%)
Côte d'Ivoire All ages Inpatient + Outpatient 9 2017 wk01 1772 (36%)
Egypt All ages Inpatient 4 2017 wk01 1194 (100%)
India All ages Inpatient + Outpatient 11 2017 wk01 1537 (82%)
Mongolia All ages Inpatient + Outpatient 7 2017 wk02 1175 (89%)
Mozambique All ages Inpatient + Outpatient 4 2017 wk01 969 (76%)
Russian Federation All ages Inpatient 18 2016 wk52 1648 (100%)
South Africa All ages Inpatient 5 2017 wk01 3409 (100%)
Thailand All ages Inpatient + Outpatient 11 2017 wk01 2752 (53%)
United Kingdomb Pediatric Inpatient 6 2017 wk39 2381c (0%)
All ages Outpatient 70 GPs

Abbreviations: GP, general practitioners; wk, weeks; y, years.

a

Canada has reported data for laboratory‐confirmed RSV‐positive cases only from 11 of its 12 sentinel sites.

b

Surveillance is restricted to England only.

c

The United Kingdom has reported case‐based data for outpatient surveillance only.